bims-micgli Biomed News
on Microglia
Issue of 2026–04–12
29 papers selected by
Matheus Garcia Fragas, Universidade de São Paulo



  1. Acta Neuropathol. 2026 Apr 06. pii: 37. [Epub ahead of print]151(1):
      Microglial dysfunction is a hallmark of Alzheimer's disease (AD), yet the molecular mechanisms driving these impairments remain poorly defined. Genetic studies implicate several AD-associated genes in regulating microglial activity, including SORL1, which encodes the sorting receptor SorLA. Although SorLA is highly expressed in microglia, its functional role in cellular homeostasis has remained unclear. Here, we investigated SorLA function using human brain tissue, primary microglia from rapid autopsies, and CRISPR-engineered human iPSC-derived microglia and neurons. Integrated multi-omics analyses, including single-cell RNA sequencing, lipidomics, and proteomics, together with biochemical and functional assays, revealed that SorLA deficiency induces endoplasmic reticulum (ER) stress and interferon signaling, promotes lipid droplet accumulation, and impairs phagocytic and immune functions. Protein co-complex mapping and structural modeling identified ER-associated proteins co-enriched with SorLA, including SUN2, calnexin (CANX), and multiple COPI complex components (COPA, COPB1, COPG1, ARCN1), implicating SorLA in ER proteostasis and intracellular trafficking. Notably, SORL1 deletion in iPSC-derived neurons recapitulated key phenotypes observed in microglia, including lipid droplet accumulation and SorLA-SUN2 co-immunoprecipitation, indicating that this ER-associated pathway operates across distinct brain cell types. Together, these findings identify an ER-related role for SorLA that extends beyond its established function in endocytic trafficking. Loss of SorLA triggers maladaptive stress responses, perturbs lipid handling, and compromises cellular resilience, thereby contributing to AD-relevant cellular dysfunction.
    Keywords:   SORL1/SorLA; Alzheimer’s disease; Endoplasmic reticulum stress (ER); Lipid metabolism; Microglia
    DOI:  https://doi.org/10.1007/s00401-026-03002-9
  2. bioRxiv. 2026 Apr 01. pii: 2025.08.06.668924. [Epub ahead of print]
      Ventral horn microglia in the spinal cord proliferate after nerve injuries and migrate towards the cell bodies of injured motoneurons surrounding them. However, the significance of microglia enwrapping axotomized motoneurons has remained unclear. Moreover, some injured motoneurons degenerate while others regenerate. In mice spinal cords we found that each motoneuron fate associates with microglia of different activation profiles. Microglia surrounding degenerating motoneurons form cell clusters that fully envelop the cell body and express high TREM2 and large CD68 granules, with female microglia expressing higher levels. Microglia surrounding motoneurons undergoing regeneration remain individualized and also upregulate TREM2 and CD68, but to a lesser extent than microglia around degenerating motoneurons. Removal of TREM2, either globally throughout development or specifically in microglia prior to nerve injuries, reduces p-SYK signaling and CD68 expression in all activated microglia, but more so inside microglia forming tight cell clusters around degenerating motoneurons. This effect is also larger in females. TREM2 absence did not prevent microglia clustering around degenerating motoneurons but prevented the loss of some small MNs. In addition, TREM2 depletion interfered with the retrograde cell body chromatolytic reaction that is characteristic of regenerating motoneurons and delayed muscle reinnervation. We conclude that within the same motor pools, TREM2 facilitates microglia removal of some degenerating motoneurons while it facilitates regeneration of other motoneurons. The signals that direct the development of these different microglia phenotypes over degenerating and regenerating motoneurons, as well as the mechanisms that induce degeneration in some motoneurons while most others regenerate, remain to be investigated.
    Significance Statement: Microglia frequently enwrap neurons undergoing cellular stress being one example the microglia reaction around motoneurons axotomized after nerve injuries. The significance of this microglia-neuron relationship is unclear. We found that microglia surrounding axotomized motoneurons upregulate TREM2, but with differences depending on whether microglia associated with regenerative or degenerative motoneurons. Loss-of-function experiments showed that TREM2 promotes removal of some degenerating motoneurons while facilitates the regeneration of others. We conclude that microglia TREM2 serves a dual function depending on the motoneuron health state. This knowledge is critical for designing future therapies that aim to improve motoneuron regeneration or preservation by altering TREM2 function.
    DOI:  https://doi.org/10.1101/2025.08.06.668924
  3. J Neurosci. 2026 Apr 10. pii: e0112262026. [Epub ahead of print]
      Ventral horn microglia in the spinal cord proliferate after nerve injuries and migrate towards the cell bodies of injured motoneurons surrounding them. However, the significance of microglia enwrapping axotomized motoneurons has remained unclear. Moreover, some injured motoneurons degenerate while others regenerate. In mice spinal cords we found that each motoneuron fate associates with microglia of different activation profiles. Microglia surrounding degenerating motoneurons form cell clusters that fully envelop the cell body and express high TREM2 and large CD68 granules, with female microglia expressing higher levels. Microglia surrounding motoneurons undergoing regeneration remain individualized and also upregulate TREM2 and CD68, but to a lesser extent than microglia around degenerating motoneurons. Removal of TREM2, either globally throughout development or specifically in microglia prior to nerve injuries, reduces p-SYK signaling and CD68 expression in all activated microglia, but more so inside microglia forming tight cell clusters around degenerating motoneurons. This effect is also larger in females. TREM2 absence did not prevent microglia clustering around degenerating motoneurons but prevented the loss of some small MNs. In addition, TREM2 depletion interfered with the retrograde cell body chromatolytic reaction that is characteristic of regenerating motoneurons and delayed muscle reinnervation. We conclude that within the same motor pools, TREM2 facilitates microglia removal of some degenerating motoneurons while it facilitates regeneration of other motoneurons. The signals that direct the development of these different microglia phenotypes over degenerating and regenerating motoneurons, as well as the mechanisms that induce degeneration in some motoneurons while most others regenerate, remain to be investigated.Significance Statement Microglia frequently enwrap neurons undergoing cellular stress being one example the microglia reaction around motoneurons axotomized after nerve injuries. The significance of this microglia-neuron relationship is unclear. We found that microglia surrounding axotomized motoneurons upregulate TREM2, but with differences depending on whether microglia associated with regenerative or degenerative motoneurons. Loss-of-function experiments showed that TREM2 promotes removal of some degenerating motoneurons while facilitates the regeneration of others. We conclude that microglia TREM2 serves a dual function depending on the motoneuron health state. This knowledge is critical for designing future therapies that aim to improve motoneuron regeneration or preservation by altering TREM2 function.
    DOI:  https://doi.org/10.1523/JNEUROSCI.0112-26.2026
  4. Alzheimers Dement. 2026 Apr;22(4): e71322
       INTRODUCTION: The olfactory system is an early target in Alzheimer's disease (AD), yet regional glial pathology interactions remain poorly defined. We examined how glial activation and pathological burden differ between the olfactory cortex (OC) and olfactory bulb (OB) across disease stages.
    METHODS: Post mortem OC and OB samples from cognitively normal (CN), mild cognitive impairment, and AD cases were analyzed using immunohistochemistry and immunofluorescence for amyloid beta (Aβ), phosphorylated tau (pTau), Iba1 (microglia), GFAP (astrocyte), and apolipoprotein E (apoE).
    RESULTS: Both regions showed stage-dependent increases in Aβ and pTau, with regionally distinct glial responses. ApoE signal varied with clinical stage rather than genotype. Co-expression analyses revealed astrocyte-linked networks in the OC and microglia-linked relationships in the OB.
    DISCUSSION: Findings demonstrate spatially heterogenous glial pathology architectures in the human olfactory system, supporting its role as an early and regionally diverse site of AD vulnerability.
    Keywords:  Alzheimer's disease; astrocytes; microglia; olfactory bulb; olfactory cortex; protein aggregation
    DOI:  https://doi.org/10.1002/alz.71322
  5. bioRxiv. 2026 Mar 12. pii: 2026.03.09.710594. [Epub ahead of print]
      Amyloid plaques are a hallmark of Alzheimer's disease (AD) progression; however, the early stages of plaque formation and the specific amyloid-beta (Aβ) species involved remain difficult to study. While post-mortem tissue provides insight into end-stage mature plaques, therapeutic development requires targeting the earliest Aβ oligomers to arrest plaque formation. Furthermore, inherently toxic soluble Aβ oligomers off-pathway from plaque formation are implicated as a driving force of AD pathology. It also remains unclear if the specific nature of key disease-relevant species can be accurately replicated in preparations of synthetic peptides.. To bridge this gap, we utilize brain organoids carrying AD mutations as a biologically authentic source for Aβ peptides and oligomers. We demonstrate that these mutations do not disrupt organoid development and that the resulting conditioned media contains Aβ oligomers with disease-relevant structures. Finally, we show that these oligomers can be concentrated and segregated via differential ultracentrifugation for further experimental applications.
    DOI:  https://doi.org/10.64898/2026.03.09.710594
  6. bioRxiv. 2026 Apr 04. pii: 2026.04.03.715591. [Epub ahead of print]
      Apolipoprotein E ( APOE ) genotype contributes significantly to Alzheimer's disease (AD) risk and pathogenesis. Cell-type specific effects of APOE alleles have been studied. However, due to the variable prevalence of APOE genotypes within human populations, characterization of cell-type specific transcriptomes across APOE genotypes has been challenging. Here, we integrated previous and newly generated single-nuclei sequencing (snRNA-seq) data in the prefrontal cortex (PFC) from individuals across APOE genotypes ( 2/2 , 2/3 , 3/3 , 3/4 , 4/4 ). Clustering analysis revealed distinct excitatory and microglial subpopulations that were uniquely enriched or depleted for APOE4/4 AD. Notably, an excitatory neuronal cluster exhibited neurofibrillary tangle (NFT) signatures and was selectively depleted in APOE4/4 AD cases. In addition, several microglial subpopulations were influenced by both APOE4 dosage and disease status. Among these, the putative AD risk gene FRMD4A emerged as APOE4 dose and AD-dependent. These findings were validated by RNAscope in an extended cohort. Together, our findings provide insights into how APOE4 reshapes cellular states and contributes to cell-type-specific vulnerability in AD.
    DOI:  https://doi.org/10.64898/2026.04.03.715591
  7. Physiol Rep. 2026 Apr;14(7): e70856
      Atherosclerosis is linked to an increased risk of cognitive decline, with chronic inflammation being a common feature of both pathologies. IL-12 activates STAT4 to regulate myeloid cell functions, and blockade of this pathway alleviates cognitive impairment in Alzheimer's models. However, the mechanisms connecting vascular pathology to neuroinflammation remain unclear. Here, we examine whether STAT4 functions as a common mediator of neuroinflammation in atherosclerosis. We demonstrate that LysMCre-specific STAT4 deficiency ameliorates deficits in long-term memory in low-density lipoprotein-deficient (Ldlr-/-) mice fed a high-fat diet (HFD-C). STAT4 deficiency moderately reduces Ser199-phosphorylated Tau burden. Atherosclerosis alters brain immune composition, characterized by increased numbers of CD45+ leukocytes, activated microglia, and activated T and B cells, whereas STAT4 deficiency attenuates these effects. Nanostring gene-expression pathway analysis further highlights the importance of STAT4 in regulating multiple neuroinflammatory pathways and the Rhodopsin-like receptor signaling, which is associated with synaptic plasticity. LysMCre-specific STAT4 deficiency supports microglial efferocytosis in atherosclerotic Ldlr-/- mice and increases the number of efferocytotic macrophages. Accordingly, STAT4 deficiency also reduces neuronal death. Overall, our data reveal an important role for myeloid-driven STAT4 expression in the pathogenesis of cognitive decline associated with atherosclerosis, mediated through impaired efferocytosis and enhanced leukocyte activation, leading to increased brain neuroinflammation.
    Keywords:  STAT4; atherosclerosis; cognitive functions; immune response; neuroinflammation
    DOI:  https://doi.org/10.14814/phy2.70856
  8. J Cereb Blood Flow Metab. 2026 Apr 04. 271678X261435369
      Microglia are the resident macrophage in the central nervous system (CNS) and are essential for maintaining homeostatic functions of the CNS. During development, the proliferation, and colonization of yolk sac-derived progenitors in the CNS are precisely regulated by a specific set of genes. Microglia also play a crucial role in CNS diseases. Microglia adopt distinct profiles to perform differential functions in various diseases. In this review, we summarize the molecular programs that govern microglial development from embryonic colonization to postnatal maturation, and highlight how these regulatory mechanisms shape microglial identity and function. We further discuss how microglia undergo profound profile transitions in cerebral disorders, especially during ischemic stroke. Together, these insights gained from recent studies highlight the need for a better understanding of the precise cell types and their stage-specific mechanism in the revolution of the immune landscape at different stages of stroke pathology. This knowledge will be valuable to design specific therapeutic strategies to reduce acute and secondary neuronal damage without further exacerbating stroke-induced immune suppression (SIIS).
    Keywords:  Microglia; infiltrating immune cells; ischemic stroke; microglial precursors; neuroinflammation
    DOI:  https://doi.org/10.1177/0271678X261435369
  9. Immunity. 2026 Apr 09. pii: S1074-7613(26)00118-4. [Epub ahead of print]
      Glial crosstalk surrounding amyloid-β (Aβ) plaques establishes a self-propagating inflammatory niche fueling Alzheimer's disease (AD), yet the molecular triggers remain incompletely defined. We found that the calcium-dependent enzyme peptidyl-arginine deiminase 2 (PAD2) was selectively upregulated in plaque-associated astrocytes in human AD cortex and multiple APP AD transgenic mouse models. Astrocyte-specific deletion of Padi2 in 5×FAD mice rescued learning and memory, lowered Aβ load, restrained pro-inflammatory microglial activation, and restored microglial phagocytosis. Multi-omics profiling tied these benefits to rewiring of the astrocytic proteome and the microglial transcriptome toward homeostasis. PAD2 converted astrocytic vimentin to citrullinated Cit-Vim175/184. The released Cit-vimentin drove a proinflammatory phenotype while dampening Aβ clearance in microglia-a process dependent on TLR4 signaling. Pharmacological PAD2 inhibition mimicked the genetic rescue, normalizing glial signatures and cognition. These findings identify PAD2-dependent vimentin citrullination as a key inter-glial signaling hub that worsens AD pathology and highlight PAD2 as a promising therapeutic target.
    Keywords:  Alzheimer’s disease; PAD2; TLR4; astrocyte; citrullination; glial crosstalk; microglia; neuroinflammation; vimentin
    DOI:  https://doi.org/10.1016/j.immuni.2026.03.007
  10. Alzheimers Dement. 2026 Apr;22(4): e71337
       INTRODUCTION: Microglia have been implicated in the templated spread of tau aggregates in tauopathies through mouse studies. However, it is unclear whether these findings translate to human disease.
    METHODS: We challenged human induced pluripotent stem cell (iPSC)-derived microglia-like-cells (iMGL) with monomeric and fibrillar recombinant tau and tau purified from Alzheimer's patient brains, examining in detail the uptake, processing, release, and seeding of tau by microglia.
    RESULTS: iMGL take up tau via lipoprotein receptor-related protein 1 (LRP)1 and heparan sulfate proteoglycans, with leucine-rich repeat kinase 2 affecting LRP1 trafficking. Monomeric tau is digested effectively with minimal effects on iMGL, but recombinant or brain-derived tau fibrils induce chemokine/interferon response subtypes, alongside downregulation of homeostatic genes. Fibrillar tau is degradation-resistant, can escape into the cytoplasm, and becomes phosphorylated on two specific residues. iMGL release partially digested fibrillar tau, including in extracellular vesicles, visualized by cryo-electron microscopy, that seed aggregation in neurons.
    DISCUSSION: Our study reveals new insights into human microglial responses to tau, highlighting opportunities to limit pathogenic tau spread.
    Keywords:  LRP1; cryo‐electron microscopy; extracellular vesicle; induced pluripotent stem cells; lipoprotein receptor‐related protein 1; microglia; phospho‐proteome; tau
    DOI:  https://doi.org/10.1002/alz.71337
  11. Mol Neurobiol. 2026 Apr 09. pii: 553. [Epub ahead of print]63(1):
      Trimethylamine oxide (TMAO), a gut microbiota metabolite, has been shown to be associated with neurological diseases, but its role in spinal cord injury (SCI) remains unclear. This study investigated the contribution of TMAO in the pathogenesis of SCI. A combination of in vivo and in vitro approaches was employed to investigate the role of TMAO in SCI. Mouse models of SCI were established to evaluate neurological function, histopathology, and inflammasome activation following TMAO treatment or inhibition. BV2 microglial cells were subjected to oxygen-glucose deprivation (OGD) to examine the impact of TMAO on neuro-inflammation and NLRP3 activation. Molecular and biochemical techniques, including western blot, immunofluorescence, and ELISA, were used to assess inflammasome signaling and inflammatory responses. The therapeutic potential of TMAO inhibition (DMB) and NLRP3 blockade (MCC950) was systematically evaluated in both animal and cellular models, along with the verification in vitro using gene knockdown. TMAO exacerbated SCI in mice, worsening weight loss, neurological deficits, and neuronal damage while increasing microglial NLRP3 inflammasome activation, inflammatory cytokine release, and immune cell infiltration. Both DMB and MCC950 attenuated these effects, restoring tissue integrity and functional recovery. In microglia, TMAO amplified NLRP3-driven neuro-inflammation under OGD condition, an effect reversed by MCC950. Notably, DMB similarly suppressed TMAO-mediated microglial activation. NLRP3 knockdown reversed the impact of TMAO on pyroptosis. Our findings demonstrate that TMAO exacerbates spinal cord injury and activates the NLRP3 inflammasome in microglia, amplifying neuro-inflammation. Inhibition of TMAO or NLRP3 attenuates these pathological effects, suggesting that targeting the TMAO-NLRP3 axis represents a promising therapeutic strategy for SCI.
    Keywords:  Gut microbiota metabolites; Inflammasome; Microglia; Neuro-inflammation; Spinal cord injury
    DOI:  https://doi.org/10.1007/s12035-026-05833-9
  12. Alzheimers Dement. 2026 Apr;22(4): e71306
       INTRODUCTION: While the apolipoprotein E (APOE) ε4 allele is a major risk factor for Alzheimer's disease (AD), the role of translocase of outer mitochondrial membrane 40 (TOMM40)-an adjacent gene involved in mitochondrial protein import-is not known.
    METHODS: Human brain tissue, human induced pluripotent stem cell-derived neurons (iNeurons), and mice were used for study of gene expression, cholesterol metabolism, mitochondrial function, and animal cognition.
    RESULTS: Human brain transcriptomics showed reduced TOMM40 expression that correlated with cholesterol regulatory gene expression, amyloid burden, and clinical AD diagnosis. In human iNeurons, TOMM40 knockdown (KD) disrupted mitochondria-endoplasmic reticulum contact sites (MERCs), causing mitochondrial dysfunction and promoting reactive oxygen species that led to activation of liver X receptor beta (NR1H2), upregulation of APOE and low-density lipoprotein receptor (LDLR), and increased cellular cholesterol and amyloid beta (Aβ)42 independent of APOE ε4. Consistently, Tomm40 KD in mice induced increased brain cholesterol, Aβ42 content, and impaired memory.
    DISCUSSION: TOMM40 is a novel mediator of AD pathology through dual effects on MERCs that regulate cholesterol homeostasis and mitochondrial function.
    Keywords:  Alzheimer's disease; apolipoprotein E; cholesterol metabolism; mitochondria; mitochondria–endoplasmic reticulum contact sites; translocase of outer mitochondrial membrane 40
    DOI:  https://doi.org/10.1002/alz.71306
  13. bioRxiv. 2026 Mar 14. pii: 2026.03.11.710133. [Epub ahead of print]
       Introduction: Disruption of brain glucose and lipid metabolism contributes to Alzheimer's disease (AD) and often emerges before clinical symptoms. Women are at elevated AD risk due to menopause-associated estrogen decline, which impairs mitochondrial function and glucose metabolism. Women's risk of AD is further elevated by the APOE4 allele, the strongest genetic risk factor for late-onset AD.
    Methods: To investigate the impact of APOE genotype on the menopausal metabolic transition, brain metabolomic and lipidomic profiling was conducted in humanized female APOE3/3, APOE3/4, and APOE4/4 mice across chronological and endocrinological stages of peri-to postmenopausal transition.
    Results: APOE3/3 mice exhibited dynamic regulation of brain metabolic systems that supported postmenopausal bioenergetic demand. In contrast, APOE3/4 and APOE4/4 mice displayed accelerated and altered metabolic shifts, resulting in postmenopausal amino acid depletion, reduced tricarboxylic acid (TCA) cycle intermediates, lipid accumulation, and alterations in brain lipid composition. A single APOE4 allele was sufficient to impair metabolic adaptation, while APOE4 homozygosity resulted in greater severity of deficits.
    Discussion: Outcomes of these analyses revealed that APOE4 accelerated menopause-related metabolic decline and compromised bioenergetic adaptation, providing a mechanistic basis for increased AD susceptibility and earlier onset in APOE4-positive women.
    DOI:  https://doi.org/10.64898/2026.03.11.710133
  14. Cell Death Discov. 2026 Apr 09.
      Lipid droplets (LDs) are dynamic intracellular organelles traditionally associated with energy storage, which have become increasingly recognised for their versatile roles in cellular metabolism and signalling. In the brain, LDs have emerged as critical regulators in neurodegenerative diseases (NDDs) such as Alzheimer's disease (AD), Parkinson's disease (PD), and Hereditary Spastic Paraplegia (HSP). LDs contribute to neurodegeneration by influencing lipid metabolism, oxidative stress, and inflammatory responses. For instance, in AD, dysregulated lipid metabolism and impaired Apolipoprotein E 4 (ApoE4) function lead to LD accumulation associated with neuroinflammation and amyloid plaque formation. In PD, interactions between LDs and α-synuclein suggest a potential link between lipid dysregulation and neurotoxicity. Mutations in LD-associated proteins, such as spastin and DDH2 in HSP, highlight the importance of proper LD regulation for neuronal health. While LD accumulation can be protective by mitigating lipotoxicity, prolonged dysregulation can exacerbate NDD pathology. Targeting LD metabolism, through enhancing lipophagy or modulating LD-associated proteins, represents a promising therapeutic avenue. This review highlights the dual roles of LDs in the brain, acting both neuroprotectively and neurotoxically, and the therapeutic potential of targeting LD dynamics for NDD treatment.
    DOI:  https://doi.org/10.1038/s41420-026-03096-w
  15. Mol Neurodegener Adv. 2026 ;2(1): 17
       Background: Understanding synapse-specific effects of neuroinflammation can provide mechanistic and therapeutically relevant insights across the spectrum of neurological diseases.
    Methods: We applied neuron-specific proteomic biotinylation in vivo, differential centrifugation of brain for crude synaptosome enrichment (P2 fraction) and mass spectrometry (MS) analysis of biotinylated proteins to derive native-state proteomes of Camk2a-positive neurons and their corresponding P2 synaptic compartments. Next, in an in vivo model of systemic lipopolysaccharide (LPS) dosing, we examined the effects of neuroinflammation on whole neuron and synaptic compartments using a combination of MS, network analysis, confirmatory biochemical and ultrastructural assays and integrative approaches across our mouse-derived and existing human datasets.
    Results: Ultrastructural and biochemical analyses of P2 fractions verified enrichment in synaptic elements, including synaptic vesicles and mitochondria. MS of biotinylated proteins from Camk2a-specific bulk brain homogenates (whole neuron) and P2 fractions (synaptosome) showed enrichment of > 1000 proteins, consistent with neuron-specific biotinylation, also confirmed by immunofluorescence microscopy. Camk2a-specific synaptic proteome revealed molecular signatures related to mitochondrial function, synaptic transmission, protein translation. LPS-treated mice displayed body weight loss and neuroinflammation, characterized by glial activation, increased pro-inflammatory cytokine levels and upregulated expression of Alzheimer's disease (AD)-related microglial genes. LPS-induced neuroinflammation exerted distinct effects on the synaptic proteome, including increased mitochondrial and reduced cytoskeletal-synaptic proteins, while suppressed synaptic MAPK signaling. Importantly, these changes were not observed at the whole neuron level, indicating unique vulnerability of the synapse to neuroinflammation. In line with synapse proteomic and signaling changes, LPS altered the ultrastructure of asymmetric synapses, suggesting dysregulation of excitatory neurotransmission. Co-expression network analysis of Camk2a neuronal proteins further resolved mitochondria- and synapse-specific protein modules, some of which were neuroinflammation-dependent. Neuroinflammation increased levels of a mitochondria-enriched module, and decreased levels of a pre-synaptic vesicle module, without impacting a post-synaptic membrane module. LPS-dependent mitochondrial and LPS-independent post-synaptic modules in mouse neurons mapped to post-mortem human AD brain proteomic modules which were decreased in cases with AD dementia and positively correlated to cognitive function, including pro-resilience markers for AD.
    Conclusion: Our findings using native-state proteomics of Camk2a neurons combined with synaptosome enrichment identify proteome-level mechanisms of early synaptic vulnerability to neuroinflammation relevant to AD.
    Graphical Abstract:
    Supplementary Information: The online version contains supplementary material available at 10.1186/s44477-026-00024-1.
    Keywords:  Alzheimer's disease; Cognitive resilience; Excitatory neuron; MAPK signaling; Mitochondria; Native-state proteomics; Neuroinflammation; Synapse vulnerability; Synaptosome
    DOI:  https://doi.org/10.1186/s44477-026-00024-1
  16. Cell Metab. 2026 Apr 07. pii: S1550-4131(26)00050-1. [Epub ahead of print]38(4): 641-642
      Chronic autoimmune inflammation is increasingly understood to be shaped by the tissue metabolic environment. Weyand and colleagues show that lipid-rich tissues trigger lipid droplet-dependent, gasdermin D-mediated pyroptosis in metabolically exhausted CD4+ T cells, thereby sustaining inflammatory pathology.
    DOI:  https://doi.org/10.1016/j.cmet.2026.02.007
  17. Nature. 2026 Apr;652(8109): 274
      
    Keywords:  Brain; Medical research; Neuroscience
    DOI:  https://doi.org/10.1038/d41586-026-01021-w
  18. J Neurochem. 2026 Apr;170(4): e70432
      Twenty different amino acids are required for the human body for proper functioning as amino acids serve as building blocks for proteins. We screened different essential and non-essential amino acids for the ability to stimulate lysosomal biogenesis and, interestingly, found an essential amino acid L-leucine as the most potent one in stimulating lysosomal biogenesis in astrocytes. However, D-leucine remained weaker than L-leucine in terms of stimulation of lysosomal biogenesis. Accordingly, L-leucine increased autophagy in cultured brain cells and in vivo in the brain of 5XFAD mice, one of the animal models of Alzheimer's disease (AD). L-Leucine also stimulated the uptake and degradation of amyloid-β in astrocytes and reduced the plaque load and improved cognitive functions in 5XFAD mice. Although L-leucine was discovered about 200 years back, until now, no receptor has been identified for L-leucine. Here, we noticed that L-leucine binds to the ligand-binding domain of peroxisome proliferator-activated receptor α (PPARα) to activate this nuclear hormone receptor. Accordingly, L-leucine remained ineffective in increasing lysosomal biogenesis and autophagy in PPARα-/- brain cells. Lentiviral establishment of full-length PPARα, but not Y314D-PPARα, reinstated the autophagy-stimulating effect of L-leucine in PPARα-/- astrocytes, emphasizing the importance of leucine's interaction with the Y314 residue. Moreover, oral L-leucine decreased the plaque load and improved spatial learning and memory in 5XFAD mice, but not in 5XFADΔPPARα mice (5XFAD lacking PPARα), highlighting the involvement of PPARα in the neuroprotective effects of L-leucine. These results may be beneficial for AD patients.
    Keywords:  Alzheimer's disease; L‐leucine; autophagy; cognitive function; lysosomal biogenesis; plaque
    DOI:  https://doi.org/10.1111/jnc.70432
  19. Brain Commun. 2026 ;8(2): fcag109
      Ferroptosis is a redox-driven and iron-dependent type of programmed cell death, with lipid peroxidation as a central and required feature of the process. During ferroptosis, cells exert strong proinflammatory effects, suggesting that ferroptosis may play a role in the regulation of inflammation and immune response. However, very few studies have investigated the process of ferroptosis and lipid peroxidation in microglia, the innate immune cells of the brain. In this review, we summarize the concept of ferroptosis and present a list of 120 ferroptosis-relevant proteins, which includes over twice as many entries as the current Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway for ferroptosis. We compare our manually compiled list with microglial activation signatures reported by us and others, revealing ferroptosis-relevant changes in models for microglial activation. Finally, we highlight a selection of ferroptosis-relevant proteins as potential biomarker candidates for ferroptosis.
    Keywords:  ferroptosis; inflammation; microglia; neuroinflammation
    DOI:  https://doi.org/10.1093/braincomms/fcag109
  20. bioRxiv. 2026 Mar 14. pii: 2026.03.11.711132. [Epub ahead of print]
       Introduction: The major histocompatibility complex class II (MHC-II) pathway is central to adaptive immunity and immune tolerance, and age-related erosion of these mechanisms is increasingly recognized as a driver of chronic neuroinflammation. The HLA-DRB1*15:01 allele-the strongest genetic risk factor for multiple sclerosis in Caucasians-has been implicated in shaping pathogenic CD4⁺ T-cell responses and broader neuroimmune vulnerability, yet how this allele modulates age- and sex-dependent neuroimmune processes within the central nervous system (CNS) remains poorly defined.
    Methods: We investigated the impact of HLA-DRB1*15:01 expression using a humanized mouse model (HLA mice) and wild-type (WT) controls. Male and female mice were analyzed at 6, 9, and 15 months of age, with endocrine stratification in females. Behavioral testing, flow cytometry, immunofluorescence, and multiplex cytokine analyses were used to assess cognitive performance, glial activation and oxidative stress, astrocyte-microglia IL-3/IL-3R signaling, endothelial activation, selective immune cell accumulation at CNS borders, tissue organization, and hippocampal cytokine profiles.
    Results: HLA mice developed age- and sex-dependent cognitive impairment, most pronounced in aged females. HLA-DRB1*15:01 expression promoted progressive microglial activation, characterized by increased CD14 and CD68 expression, elevated mitochondrial oxidative stress, altered astrocyte phenotypes, and enhanced IL-3/IL-3R signaling. Hippocampal axonal and myelin organization was disrupted in aged HLA mice, and this disruption was spatially associated with increased microglial presence. At CNS interfaces, HLA mice exhibited selective immune remodeling, including increased accumulation of CD4⁺ T cells and NK1.1⁺CD3⁺ natural killer T (NKT) cells, particularly in females, accompanied by endothelial activation, as evidenced by elevated ICAM-1 and E-selectin expression. Hippocampal cytokine profiling revealed selective, sex-biased alterations, including increased IL-12p70 and reduced IL-10 and IL-2, without broad induction of classical inflammatory cytokines.
    Conclusion: Together, these findings demonstrate that HLA-DRB1*15:01 drives a coordinated, age- and sex-dependent neuroinflammatory program linking behavioral dysfunction, glial activation and oxidative stress, selective immune cell recruitment, endothelial activation, tissue remodeling, and targeted cytokine imbalance. This integrated phenotype provides mechanistic insight into how this major MS risk allele confers vulnerability to chronic neuroinflammation during aging, with heightened impact in females.
    DOI:  https://doi.org/10.64898/2026.03.11.711132
  21. bioRxiv. 2026 Apr 03. pii: 2026.04.02.716170. [Epub ahead of print]
      Sleep is thought to be important for the clearance of brain waste, but exactly how it does so is still debated. Here, we demonstrate that endocytosis in brain endothelial cells (BECs) of the blood-brain barrier (BBB) is enhanced during sleep, facilitating the removal of brain-derived waste, including amyloid-β, into the circulation. Using proteomics, in vivo tracer imaging, and endothelial-specific genetic perturbations in mice, we demonstrate that sleep enhances endocytic vesicle formation and cargo transcytosis in brain endothelial cells (BECs). Conversely, blocking endocytosis through endothelial Dnm2 knockout suppresses BEC-mediated transport and elevates sleep need, revealing a causal feedback loop between sleep and vascular endocytosis. These findings identify BBB endocytosis as a key sleep-dependent clearance pathway with implications for neurodegenerative disease.
    DOI:  https://doi.org/10.64898/2026.04.02.716170
  22. Brain Pathol. 2026 Apr 06. e70090
      Transmembrane protein 106B (TMEM106B) is a lysosomal glycoprotein whose genetic polymorphisms contribute to the severity of neurodegenerative disorders associated with TDP-43 pathology. Recent studies have revealed that TMEM106B can form amyloid filaments composed of C-terminal fragments (CTFs) in the human brain. In the present study, we explored the relationships between TMEM106B, age, TDP-43, and tau aggregates, and their roles in neurodegeneration. We used immunohistochemistry with an antibody against CTFs of TMEM106B on postmortem human brain fragments (amygdala, hippocampus, temporal cortex, frontal cortex, and basal ganglia) from patients with and without TDP-43/tau pathology at different ages (6-94 years) and with different neurological conditions (subacute sclerosing panencephalitis, Alzheimer's disease, frontotemporal lobar degeneration, and neurologically healthy subjects). Our results revealed that TMEM106B CTF fibrillization is a common, nonspecific, diffuse, and age-dependent phenomenon (appearing after >52 years of age) that affects neurons and neuroglia (most numerous in astrocytes and oligodendrocytes) and broad neuroanatomical regions (most severe in the temporal cortex). We did not find TMEM106B CTF aggregates in young subjects with TDP-43/tau pathology (with subacute sclerosing panencephalitis), but we revealed differences in TMEM106B CTF fibrillization between Alzheimer's disease without TDP-43 pathology, frontotemporal lobar degeneration with TDP-43 pathology, and older healthy subjects without TDP-43/tau pathology. Our results suggest that TMEM106B CTF aggregation is an age-dependent phenomenon and may have a weak association with TDP-43 or tau pathology, shedding new light on the complex relationships among TMEM106B, TDP-43, and tau and the unclear role of TMEM106B fibril formation in the neurodegeneration process.
    Keywords:  Alzheimer's disease; TDP‐43; TMEM106B; immunohistochemistry; pathology; tau
    DOI:  https://doi.org/10.1111/bpa.70090
  23. bioRxiv. 2026 Mar 30. pii: 2026.03.27.714902. [Epub ahead of print]
      Loss of proteostasis and the accumulation of insoluble protein aggregates are features of aging across model organisms and occur in all major age-related neurodegenerative diseases; yet how aggregation proceeds during normal human brain aging remains unknown. Here, using detergent-fractionation proteomics, we show that brain aging does not involve uniform aggregate accumulation; rather, the insoluble proteome undergoes asymmetric remodeling beginning in midlife, with maximum-stability aggregates declining sharply by old age and intermediate-stability aggregates accumulating progressively before accelerating after age 80. Intermediate-stability aggregates are prone to liquid-liquid phase separation and are enriched among Alzheimer's disease plaque and tangle constituents. Proteasome and cytosolic chaperone capacity predict individual differences in aggregate burden as strongly as chronological age, offering human-level evidence in support of therapies targeting these pathways. These findings establish aggregate remodeling as a feature of normal brain aging and position intermediate-stability aggregate accumulation as a molecular event on the path to neurodegenerative disease.
    DOI:  https://doi.org/10.64898/2026.03.27.714902
  24. Alzheimers Dement. 2026 Apr;22(4): e71273
       INTRODUCTION: Alzheimer's disease (AD) exhibits high genetic and clinical heterogeneity that limits therapeutic success. Patient-derived brain organoids and their extracellular vesicles (EVs) provide physiologically relevant models to study disease mechanisms and individualized drug responses.
    METHODS: We generated the largest brain organoid cohort to date, derived from 30 independent induced pluripotent stem cell (iPSC) lines from AD and control individuals. Comparative proteomic profiling was performed on both organoids and their secreted EVs to capture molecular diversity and treatment effects.
    RESULTS: Organoids and EVs consistently recapitulated neuronal proteomic signatures and revealed early alterations in AD-related pathways, including synaptic and neurotransmitter dysfunction. Distinct proteomic responses mirrored individual variability in selective serotonin reuptake inhibitor sensitivity.
    DISCUSSION: Integrating organoid and EV data provides a systems-level view of AD pathophysiology and treatment response, positioning this dual-platform model as a cost-effective tool for precision medicine and drug discovery.
    Keywords:  Alzheimer disease; clinical heterogeneity; escitalopram oxalate; extracellular vesicle proteomics; extracellular vesicles; induced pluripotent stem cells; proteomic profiling; serotonergic hindbrain organoids
    DOI:  https://doi.org/10.1002/alz.71273
  25. Sci Adv. 2026 Apr 10. 12(15): eadw1038
      Tissue-resident memory T cells (TRM cells) reside in nonlymphoid tissues and provide the first line of defense against pathogens. A subset of TRM cells can egress from nonlymphoid tissues into the circulation. However, the functional consequences and the extent of epigenetic imprinting in recirculating TRM cells remain unknown. We herein demonstrate that in CD4+ TRM cells, the CD69-S1PR1 axis controls tissue residency and that interrupting this axis results in ablation of lung CD4+ TRM cells. A subpopulation of CD69+CD4+ TRM cells reentered circulation via lymphatic vessels, where they epigenetically maintained the characteristics of TRM cells in both mice and humans. Circulating Ex-lung-TRM cells in mice caused enhanced skin inflammation compared to circulating memory cells. Furthermore, we identified GPR183 and CD161 as potential markers of Ex-TRM in human peripheral blood mononuclear cells. In chronic inflammatory diseases, the transposition of allergic inflammation to multiple tissues may therefore occur via recirculation of tissue-imprinted memory CD4+ T cells.
    DOI:  https://doi.org/10.1126/sciadv.adw1038
  26. Neurobiol Dis. 2026 Apr 08. pii: S0969-9961(26)00131-2. [Epub ahead of print] 107386
      Hippocampal neuroinflammation is a key contributor to cognitive deficits in multiple neurological disorders, yet the intrinsic mechanisms that restrain excessive microglial activation remain incompletely understood. Numb, which is highly expressed in hippocampal microglia, is identified here as an important modulator of inflammatory responses. We show that Numb expression is reduced under neuroinflammatory conditions, and that conditional knockout of Numb in microglia in lipopolysaccharide-exposed mice leads to enhanced neuroinflammation, neuronal injury, and inflammation-associated behavioral impairments. In vitro, Numb deficiency in microglia enhances inflammatory responses and consequently promotes microglia-mediated neuronal damage. At the mechanistic level, Numb interacts with the innate immune sensor Ifi204 and suppresses Ifi204-TLR4 signaling under inflammatory conditions. Moreover, Numb deficiency impairs autophagic flux and reduces lysosomal acidification, accompanied by increased Ifi204 accumulation. Collectively, these findings establish microglial Numb as an intrinsic checkpoint that restrains hippocampal neuroinflammation and preserves neuronal integrity, thereby highlighting its potential as a therapeutic target for cognitive dysfunction associated with neuroinflammatory conditions.
    Keywords:  Cognitive dysfunction; Microglia; Neuroinflammation; Numb
    DOI:  https://doi.org/10.1016/j.nbd.2026.107386